Harbin Pharmaceutical Group Co

Harbin Pharmaceutical Group Co Goodwill

The Goodwill of Harbin Pharmaceutical Group Co (600664.SS) as of Oct 25, 2026 is 39.16 M CNY. In the previous year, Goodwill was 39.16 M CNY — a change of 0.00% (lower).

Goodwill

39.16 MCNY

YoY

0.00%

Last updated:

Goodwill of Harbin Pharmaceutical Group Co is 2025 39.16 M CNY. Goodwill of Harbin Pharmaceutical Group Co was 2024 39.16 M CNY. It decreases by 0.00% lower compared to the previous year.

The Harbin Pharmaceutical Group Co Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2016
1.28 M CNY
Jan 1, 2017
1.28 M CNY
Jan 1, 2020
0.00 CNY
Jan 1, 2021
39.15 M CNY
Jan 1, 2022
39.15 M CNY
Jan 1, 2023
39.15 M CNY
Jan 1, 2024
39.16 M CNY
Jan 1, 2025
39.16 M CNY
The Harbin Pharmaceutical Group Co Goodwill history
YEARGoodwillYoY
39.16 MCNY0.00%
39.16 MCNY+0.03%
39.15 MCNY0.00%
39.15 MCNY0.00%
39.15 MCNY—
0.00CNY-100.00%
1.28 MCNY0.00%
1.28 MCNY0.00%
1.28 MCNY-82.65%
7.40 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Harbin Pharmaceutical Group Co Stock analysis

What does Harbin Pharmaceutical Group Co do? Harbin Pharmaceutical Group Co., Ltd. generates revenue by engaging in the research, development, manufacture, wholesale, and retail of pharmaceutical products. The firm focuses on innovative research and development in high-tech fields such as antibiotics, modern Chinese medicine, and biopharmaceuticals. These activities support its main business sectors, which include antibiotics, over-the-counter drugs and health products, traditional and modern Chinese medicine, biomedicine, and pharmaceutical commerce. The company produces a wide range of items, including calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsules, Shuanghuanglian oral solution, alprostadil injection, pediatric paracetamol Huangnamin granules, lacidipine tablets, hydrochloric acid for injection Cefotiam, ibuprofen granules, and Xingaizhonggai high calcium tablets. The business is structured around these diverse product lines, serving the needs of the pharmaceutical commerce sector and consumers requiring specific medical treatments. By covering the entire value chain from research and development to retail, the company monetizes its expertise in high-tech fields. The products listed, such as Shuanghuanglian oral solution and amoxicillin capsules, represent the tangible outputs of its manufacturing and wholesale operations, which are central to its financial model. Harbin Pharmaceutical Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harbin Pharmaceutical Group Co stock

Goodwill of Harbin Pharmaceutical Group Co is 39.16 M CNY in 2025.

Goodwill of Harbin Pharmaceutical Group Co changed from 39.16 M CNY to 39.16 M CNY, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill Harbin Pharmaceutical Group Co since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Harbin Pharmaceutical Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Harbin Pharmaceutical Group Co

All Key Metrics — Harbin Pharmaceutical Group Co